- Home
- MGRC vs CRNX Comparison
MGRC vs CRNX Comparison
Compare MGRC & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- CRNX
- Stock Information
- Founded
- MGRC 1979
- CRNX 2008
- Country
- MGRC United States
- CRNX United States
- Employees
- MGRC N/A
- CRNX N/A
- Industry
- MGRC Diversified Commercial Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- CRNX Health Care
- Exchange
- MGRC Nasdaq
- CRNX Nasdaq
- Market Cap
- MGRC 2.8B
- CRNX 2.8B
- IPO Year
- MGRC N/A
- CRNX 2018
- Fundamental
- Price
- MGRC $119.97
- CRNX $32.47
- Analyst Decision
- MGRC Buy
- CRNX Strong Buy
- Analyst Count
- MGRC 2
- CRNX 10
- Target Price
- MGRC $145.50
- CRNX $75.00
- AVG Volume (30 Days)
- MGRC 173.2K
- CRNX 654.7K
- Earning Date
- MGRC 07-24-2025
- CRNX 08-07-2025
- Dividend Yield
- MGRC 1.63%
- CRNX N/A
- EPS Growth
- MGRC 88.16
- CRNX N/A
- EPS
- MGRC 9.65
- CRNX N/A
- Revenue
- MGRC $918,531,000.00
- CRNX $760,000.00
- Revenue This Year
- MGRC $6.11
- CRNX $402.12
- Revenue Next Year
- MGRC $5.52
- CRNX $770.88
- P/E Ratio
- MGRC $12.31
- CRNX N/A
- Revenue Growth
- MGRC 7.31
- CRNX N/A
- 52 Week Low
- MGRC $95.50
- CRNX $24.10
- 52 Week High
- MGRC $129.93
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- MGRC 57.59
- CRNX 50.56
- Support Level
- MGRC $118.25
- CRNX $28.98
- Resistance Level
- MGRC $122.28
- CRNX $30.34
- Average True Range (ATR)
- MGRC 2.64
- CRNX 1.11
- MACD
- MGRC 0.30
- CRNX -0.01
- Stochastic Oscillator
- MGRC 72.27
- CRNX 66.46
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used primarily as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.